Navigation Links
Chinese pharma-biotech dragon rears its head

- I am on the eve of departing for Osaka, Japan, for the Bio Japan 2006 conference as part of a small Illinois mission. I have written a number of times over the years about both the Japanese pharma and biotech industries, but I haven't been back to Japan for a few years and I'm looking forward to getting up to speed on t......

Full article >>> forward aggressively to implement common drug development parameters existing in countries such as the U.S. and Europe; in September 2003, they put into place Good Clinical Practice (GCP) standards. This measure alone has significant impact on the performance of clinical trials in China in a manner consistent with world-class standards.

The impact of GCP means not only the potential usabi......

Full article >>> cation.

According to a Sept. 1 article of Genetic Engineering News on "Chinese Biogenerics," 95 percent of Chinese pharmaceutical products are generic. As patents now are being implemented, however, the growth of the proprietary and innovative drugs is growing rapidly.

Before the 1990s, Chinese pharmaceutical companies were unable t......

Full article >>> up its deficiencies in patent law beginning with the September 2002 "Regulations for Implementation of the Drug Administration Law," which modified the definition of a new drug to that of a drug that never been marketed or sold previously in China) Furthermore, China's patent law was amended on December 12, 2002 to harmonize China's patent system with other WTO countries.

China will have ......

Full article >>> Pharmaceutical.

Hangzhou Jiuyuan Gene Engineering.

Hualan Biological Engineering.

NCPC Genetech Biotechnology.

Source: "Chinese Biogenerics," Genetic Engineering News, Sept. 1, 2006.

Chinese biogeneric companies have focused their efforts to date on such drugs as interferon, interleukins, GM-CMF, Erythropoetin (EPO), Hepatitis B vaccine, and re......

Full article >>> t shines among best hospitals in U.S.

Michael Rosen: The world of in-vitro diagnostics is another Midwest success story

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/4/2016)... 2016  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual ... of intellectual property, today provided an update on the ... District of Texas and announcing ... Inter Partes Re-examination ("IPR") proceedings that VTech and ... was initiated on only certain claims of two of ...
(Date:2/3/2016)... DIEGO , Feb. 3, 2016   ... company with the first pluripotent stem cell-derived islet ... diabetes in clinical-stage development, today announced that ViaCyte ... Pharmaceutical Companies of Johnson & Johnson, have agreed ... group into ViaCyte.  The agreement provides ViaCyte with ...
(Date:2/3/2016)... NEW BRUNSWICK, N.J. , Feb. 3, 2016 ... 30 grants totaling more than $1 million for ... who are working on health-related research that demonstrates ... , this round of funding for the New ... available for faculty members at these educational institutions— ...
(Date:2/3/2016)... Feb. 3, 2016  Silk Therapeutics, Inc., today announced the ... Therapeutics has now raised a total of $10.25 million in ... company. The Series A2 round was led by existing investor ... with participation from new investors Lear Corporation and Highland Consumer ... P. Disney ; Richard Sackler , MD, with Summer ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016  Based on ... Frost & Sullivan recognizes US-based Intelligent Retinal Imaging ... & Sullivan Award for New Product Innovation. IRIS, ... North America , is poised ... rapidly growing diabetic retinopathy market. The IRIS technology ...
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
(Date:1/28/2016)... SAN JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: ... financial results for its second quarter ended December 31, 2015. ... the second quarter of fiscal 2016 increased 2 percent compared to ... the second quarter of fiscal 2016 was $35.0 million, or $0.93 ... Non-GAAP net income for the first quarter of fiscal 2016 ...
Breaking Biology News(10 mins):